FDA Pediatric/Counterterrorism Office Selects New Director
This article was originally published in The Pink Sheet Daily
The Office of Counter-Terrorism and Pediatric Drug Development selects Deputy Director Rosemary Roberts to head office. OCTAP Director Dianne Murphy will dedicate herself full-time to her other position as pediatric therapeutics director.
You may also be interested in...
Office of Counter-Terrorism & Pediatric Drug Development Director Dianne Murphy, MD, will leave that position in September to dedicate herself full-time to her other position in the Office of the Commissioner as office of pediatric therapeutics director
Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.
The U.K.’s Health and Social Care Bill was introduced into Parliament on Jan. 19, offering a new commercial landscape best navigated by pharma through bolstered relationships with general practitioners.